| Ticker Details |
Lifevantage Corporation
Lifevantage Corp is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products including Protandim, LifeVantage TrueScience and Canine Health.
|
| IPO Date: |
May 1, 1994 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$78.85M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 2.93%
|
| Avg Daily Range (30 D): |
$0.58 | 7.06%
|
| Avg Daily Range (90 D): |
$0.36 | 5.52%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.08M |
| Avg Daily Volume (30 D): |
.67M |
| Avg Daily Volume (90 D): |
.33M |
| Trade Size |
| Avg Trade Size (Sh.): |
138 |
| Avg Trade Size (Sh.) (30 D): |
112 |
| Avg Trade Size (Sh.) (90 D): |
100 |
| Institutional Trades |
| Total Institutional Trades: |
85 |
| Avg Institutional Trade: |
$1.82M |
| Avg Institutional Trade (30 D): |
$2.5M |
| Avg Institutional Trade (90 D): |
$2.5M |
| Avg Institutional Trade Volume: |
.16M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.32M |
| Avg Closing Trade (30 D): |
$3.38M |
| Avg Closing Trade (90 D): |
$3.38M |
| Avg Closing Volume: |
314.96K |
|
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$.46
|
$.11
|
$.02
|
|
Diluted EPS
|
$.45
|
$.11
|
$.02
|
|
Revenue
|
$195.32M
|
$43.72M
|
$48.93M
|
|
Gross Profit
|
$152.62M
|
$34.54M
|
$36.21M
|
|
Net Income / Loss
|
$5.75M
|
$1.36M
|
$.28M
|
|
Operating Income / Loss
|
$6.58M
|
$1.68M
|
$.49M
|
|
Cost of Revenue
|
$42.7M
|
$9.17M
|
$12.72M
|
|
Net Cash Flow
|
$-9.99M
|
$2.3M
|
$-2.91M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 19, 2015
|
1:7
|
|
Oct 05, 2004
|
1:68
|
|
|
|
